Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Joëlle Vermeulen(Ghent University Hospital), Jo Vandesompele(Ghent University), Jan Hellemans(Helen Keller International), Ruth Ladenstein(St Anna Children's Hospital), Katrien Swerts(Ghent University Hospital), Nadine Van Roy(Ghent University Hospital), Ulrike Pötschger(St Anna Children's Hospital), S Araneda Bravo(Queen Fabiola Children's University Hospital), Jean Michon(Université Paris Sciences et Lettres), Olivier Delattre(Institut Curie), Adela Cañete(Universitat de València), Frank Speleman(Ghent University), Katleen De Preter(Ghent University Hospital), Bárbara Marques(National Institute of Health Dr. Ricardo Jorge), Michael D. Hogarty(Children's Hospital of Philadelphia), Gian Paolo Tonini(Città della Speranza Foundation), Geneviève Laureys(Ghent University Hospital), Isabelle Janoueix‐Lerosey(Inserm), Liesbeth Vercruysse(Ghent University Hospital), Rosa Noguera(Universitat de València), André Oberthuer, Matthias Fischer(University of Cologne), Marta Piqueras(Universitat de València), Victoria Castel, Valérie Combaret(Cancer Clinic), Gudrun Schleiermacher(Inserm), Peter F. Ambros(St Anna Children's Hospital), Paola Scaruffi(Azienda Ospedaliera S.Maria), Klaus Beiske(Oslo University Hospital), Patrick McGrady(University of Florida), Bruno De Bernardi(Istituto Giannina Gaslini), Hervé Rubie, Jean Bénard(Institut Gustave Roussy), Arlene Naranjo(University of Florida), Janice Kohler(Southampton General Hospital), Wendy B. London(Dana-Farber Cancer Institute)
The Lancet Oncology
June 9, 2009
Cited by 196


Related Papers